Hepatitis B surface antigen-positive organ transplantation recipients: can lamivudine alter their fate?

J Gastroenterol Hepatol. 2001 Sep;16(9):955-7. doi: 10.1046/j.1440-1746.2001.02578.x.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Carrier State / drug therapy*
  • Carrier State / immunology
  • Disease Progression
  • Hepatitis B / drug therapy*
  • Hepatitis B / immunology
  • Hepatitis B / mortality
  • Hepatitis B Surface Antigens / blood*
  • Humans
  • Lamivudine / therapeutic use*
  • Liver Function Tests
  • Organ Transplantation*
  • Postoperative Complications / drug therapy*
  • Postoperative Complications / immunology
  • Postoperative Complications / mortality
  • Survival Rate
  • Transplantation Immunology
  • Treatment Outcome
  • Virus Activation / drug effects*
  • Virus Activation / immunology

Substances

  • Hepatitis B Surface Antigens
  • Lamivudine